Updated Jul 16, 2026
Abecassis Michael M is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Michael M. Abecassis is a corporate insider and director at PharmaCyte Biotech, Inc., a clinical-stage biotechnology company focused on developing cellular therapies for cancer and diabetes. He has been involved in the company through SEC filings, indicating his role in its governance.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-12 | PMCB | PharmaCyte Biotech, Inc. | F — Tax withholding / forfeiture | 16.9K | $1.02 | $17K |
| 2025-12-12 | PMCB | PharmaCyte Biotech, Inc. | A — Grant or award | 37.5K | $0.00 |
Michael M. Abecassis is a corporate insider and director at PharmaCyte Biotech, Inc., a clinical-stage biotechnology company focused on developing cellular therapies for cancer and diabetes. He has been involved in the company through SEC filings, indicating his role in its governance.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Abecassis Michael M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.